Trobix Bio

Trobix Bio is at the forefront of biotechnology research, pioneering precision human microbiome therapeutics. Leveraging the innovative TBX™ technology platform, Trobix Bio utilizes CRISPR, phage, and synthetic biology to reprogram specific activities in targeted microbiome bacteria. This groundbreaking approach is focused on discovering and developing orally administered precision oncology therapeutics.

Based in Tel Aviv, IL, Trobix Bio is dedicated to advancing the field of microbiome therapeutics. The company's commitment to innovation and precision positions it as a key player in the future of oncology treatment. Trobix Bio’s strategic approach promises to revolutionize how we address and treat cancer, offering new hope and improved outcomes for patients worldwide.

With a focus on precision and innovation, Trobix Bio is poised to make significant contributions to the biotechnology landscape. The company's pioneering work in microbiome therapeutics underscores its dedication to improving human health. Trobix Bio welcomes you to explore the future of precision medicine. Company information is being completed with the support of the company’s management.

To the manager of Trobix Bio, we invite you to create a customized and exclusive company showcase and product listing on our platform.